Zachary Hartman, PhD, is associate professor of surgery, integrative immunology, and pathology at the Duke University School of Medicine. He is also a member of the Duke Cancer Institute. His research focuses on non-viral and viral vaccines, immune checkpoint inhibitors, immune agonists, anti-tumor antibodies, antibody-drug conjugates, and strategies to stimulate innate and adaptive immune responses in tumors.